428 related articles for article (PubMed ID: 26572535)
1. The Role of the Protein Quality Control System in SBMA.
Rusmini P; Crippa V; Cristofani R; Rinaldi C; Cicardi ME; Galbiati M; Carra S; Malik B; Greensmith L; Poletti A
J Mol Neurosci; 2016 Mar; 58(3):348-64. PubMed ID: 26572535
[TBL] [Abstract][Full Text] [Related]
2. Synergic prodegradative activity of Bicalutamide and trehalose on the mutant androgen receptor responsible for spinal and bulbar muscular atrophy.
Giorgetti E; Rusmini P; Crippa V; Cristofani R; Boncoraglio A; Cicardi ME; Galbiati M; Poletti A
Hum Mol Genet; 2015 Jan; 24(1):64-75. PubMed ID: 25122660
[TBL] [Abstract][Full Text] [Related]
3. Proteasomal and autophagic degradative activities in spinal and bulbar muscular atrophy.
Rusmini P; Bolzoni E; Crippa V; Onesto E; Sau D; Galbiati M; Piccolella M; Poletti A
Neurobiol Dis; 2010 Nov; 40(2):361-9. PubMed ID: 20621188
[TBL] [Abstract][Full Text] [Related]
4. Autophagic and Proteasomal Mediated Removal of Mutant Androgen Receptor in Muscle Models of Spinal and Bulbar Muscular Atrophy.
Cicardi ME; Cristofani R; Crippa V; Ferrari V; Tedesco B; Casarotto E; Chierichetti M; Galbiati M; Piccolella M; Messi E; Carra S; Pennuto M; Rusmini P; Poletti A
Front Endocrinol (Lausanne); 2019; 10():569. PubMed ID: 31481932
[TBL] [Abstract][Full Text] [Related]
5. Clearance of the mutant androgen receptor in motoneuronal models of spinal and bulbar muscular atrophy.
Rusmini P; Crippa V; Giorgetti E; Boncoraglio A; Cristofani R; Carra S; Poletti A
Neurobiol Aging; 2013 Nov; 34(11):2585-603. PubMed ID: 23810450
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the Androgen Receptor by Antiandrogens in Spinobulbar Muscle Atrophy.
Baniahmad A
J Mol Neurosci; 2016 Mar; 58(3):343-7. PubMed ID: 26563449
[TBL] [Abstract][Full Text] [Related]
7. Role of androgen receptor polyQ chain elongation in Kennedy's disease and use of natural osmolytes as potential therapeutic targets.
Kumar R
IUBMB Life; 2012 Nov; 64(11):879-84. PubMed ID: 23024039
[TBL] [Abstract][Full Text] [Related]
8. Human adipose-derived mesenchymal stem cells as a new model of spinal and bulbar muscular atrophy.
Dossena M; Bedini G; Rusmini P; Giorgetti E; Canazza A; Tosetti V; Salsano E; Sagnelli A; Mariotti C; Gellera C; Navone SE; Marfia G; Alessandri G; Corsi F; Parati EA; Pareyson D; Poletti A
PLoS One; 2014; 9(11):e112746. PubMed ID: 25392924
[TBL] [Abstract][Full Text] [Related]
9. Aberrant Autophagic Response in The Muscle of A Knock-in Mouse Model of Spinal and Bulbar Muscular Atrophy.
Rusmini P; Polanco MJ; Cristofani R; Cicardi ME; Meroni M; Galbiati M; Piccolella M; Messi E; Giorgetti E; Lieberman AP; Milioto C; Rocchi A; Aggarwal T; Pennuto M; Crippa V; Poletti A
Sci Rep; 2015 Oct; 5():15174. PubMed ID: 26490709
[TBL] [Abstract][Full Text] [Related]
10. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy.
Thomas PS; Fraley GS; Damian V; Woodke LB; Zapata F; Sopher BL; Plymate SR; La Spada AR
Hum Mol Genet; 2006 Jul; 15(14):2225-38. PubMed ID: 16772330
[TBL] [Abstract][Full Text] [Related]
11. X-Linked Spinal and Bulbar Muscular Atrophy: From Clinical Genetic Features and Molecular Pathology to Mechanisms Underlying Disease Toxicity.
Cortes CJ; La Spada AR
Adv Exp Med Biol; 2018; 1049():103-133. PubMed ID: 29427100
[TBL] [Abstract][Full Text] [Related]
12. Role of the androgen receptor CAG repeat polymorphism in prostate cancer, and spinal and bulbar muscular atrophy.
Kumar R; Atamna H; Zakharov MN; Bhasin S; Khan SH; Jasuja R
Life Sci; 2011 Mar; 88(13-14):565-71. PubMed ID: 21284948
[TBL] [Abstract][Full Text] [Related]
13. An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy.
Orr CR; Montie HL; Liu Y; Bolzoni E; Jenkins SC; Wilson EM; Joseph JD; McDonnell DP; Merry DE
J Biol Chem; 2010 Nov; 285(46):35567-77. PubMed ID: 20826791
[TBL] [Abstract][Full Text] [Related]
14. Molecular Mechanisms and Therapeutics for SBMA/Kennedy's Disease.
Arnold FJ; Merry DE
Neurotherapeutics; 2019 Oct; 16(4):928-947. PubMed ID: 31686397
[TBL] [Abstract][Full Text] [Related]
15. Spinal and bulbar muscular atrophy: From molecular pathogenesis to pharmacological intervention targeting skeletal muscle.
Marchioretti C; Andreotti R; Zuccaro E; Lieberman AP; Basso M; Pennuto M
Curr Opin Pharmacol; 2023 Aug; 71():102394. PubMed ID: 37463556
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA).
Banno H; Katsuno M; Suzuki K; Tanaka F; Sobue G
Cell Tissue Res; 2012 Jul; 349(1):313-20. PubMed ID: 22476656
[TBL] [Abstract][Full Text] [Related]
17. A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy.
Bott LC; Badders NM; Chen KL; Harmison GG; Bautista E; Shih CC; Katsuno M; Sobue G; Taylor JP; Dantuma NP; Fischbeck KH; Rinaldi C
Hum Mol Genet; 2016 May; 25(10):1979-1989. PubMed ID: 26962150
[TBL] [Abstract][Full Text] [Related]
18. [Triplet repeat disease, with particular emphasis of spinal and bulbar muscular atrophy (SBMA)].
Sobue G
Rinsho Shinkeigaku; 2000 Dec; 40(12):1193-5. PubMed ID: 11464455
[TBL] [Abstract][Full Text] [Related]
19. Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease.
Breza M; Koutsis G
J Neurol; 2019 Mar; 266(3):565-573. PubMed ID: 30006721
[TBL] [Abstract][Full Text] [Related]
20. Antiandrogen flutamide protects male mice from androgen-dependent toxicity in three models of spinal bulbar muscular atrophy.
Renier KJ; Troxell-Smith SM; Johansen JA; Katsuno M; Adachi H; Sobue G; Chua JP; Sun Kim H; Lieberman AP; Breedlove SM; Jordan CL
Endocrinology; 2014 Jul; 155(7):2624-34. PubMed ID: 24742193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
